Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV

被引：0
作者：
Dagogo-Jack, Samuel
Pratley, Richard E.
Cherney, David
Charbonnel, Bernard
Mcguire, Darren K.
Cosentino, Francesco
Shih, Weichung J.
Liu, Jie
Frederich, Robert
Mancuso, James P.
Raji, Annaswamy
Gantz, Ira
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-786-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
786-P
引用
收藏
页数：4
相关论文
共 8 条
[1]  
[Anonymous], 2020, HEALIO
[2]  
CHARBONNEL BERNARD, DIABETES
[3]  
CHERNEY DAVID, DIABETES
[4]  
Dagogo-Jack S., Diabetes
[5]   Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients [J].
Matsumoto, Morio ;
Suzuki, Kenshi ;
Kuroda, Junya ;
Taniwaki, Masafumi ;
Sunami, Kazutaka ;
Kosugi, Hiroshi ;
Ando, Kiyoshi ;
Maruyama, Dai ;
Tobinai, Kensei ;
Kher, Uma ;
Farooqui, Mohammed ;
Liao, Jason ;
Marinello, Patricia ;
Matsuda, Kenji ;
Koh, Yasuhiro ;
Shimamoto, Takashi ;
Iida, Shinsuke .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (06) :777-784
[6]   Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits [J].
McGuire, Darren K. ;
Inzucchi, Silvio E. ;
Johansen, Odd Erik ;
Rosenstock, Julio ;
George, Jyothis T. ;
Marx, Nikolaus .
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
[7]   Efficacy of Semaglutide vs. Dulaglutide across Baseline HbA1c in SUSTAIN 7 [J].
Pratley, Richard E. ;
Frias, Juan P. ;
Kumar, Harish ;
Petrie, John ;
Navarria, Andrea ;
Nielsen, Morten Abildlund ;
Schmidt, Wolfgang E. .
DIABETES, 2018, 67
[8]  
PRATLEY RICHARD E., DIABETES
1